Rituximab is effective in severe treatment-resistant neurological Behçet's syndrome.
Saved in:
| Title: | Rituximab is effective in severe treatment-resistant neurological Behçet's syndrome. |
|---|---|
| Authors: | Kidd DP; Department of Clinical Neurosciences, Royal Free Hospital, Pond Street, London, NW3 2QG, UK. d.kidd@ucl.ac.uk.; Behçet's Syndrome Centre of Excellence, Dental Institute, Royal London Hospital, Whitechapel, London, E1 1BB, UK. d.kidd@ucl.ac.uk. |
| Source: | Journal of neurology [J Neurol] 2015 Dec; Vol. 262 (12), pp. 2676-7. Date of Electronic Publication: 2015 Sep 26. |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0423161 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1459 (Electronic) Linking ISSN: 03405354 NLM ISO Abbreviation: J Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
